Stefano Pluchino
Stefano Pluchino | |
|---|---|
| Born | May 31, 1971 |
| Alma mater |
|
| Known for |
|
| Scientific career | |
| Fields |
|
| Institutions | University of Cambridge |
| Thesis | Development of a neural stem cell-based therapy for experimental multiple sclerosis in mice (2004) |
| Doctoral advisor | Gianvito Martino |
Stefano Pluchino (born May 31, 1971) is Professor of Regenerative Neuroimmunology, within the Department of Clinical Neurosciences, at the University of Cambridge. His research studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies. [1] [2] [3] [4][5][6] The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells, gene therapy vectors and/or exosomes to create an environment that preserves damaged axons or prevents neurons from dying.[1][3] Such mechanisms are being harnessed and used to modulate disease states to repair and/or regenerate critical components of the nervous system.
His research focuses on understanding and modifying the mechanisms underlying neurological disability in chronic inflammatory neurological conditions, with the aim of developing next-generation molecular therapies. His pioneering work established, through two landmark Nature papers, that adult neural stem cells (NSCs) could induce recovery in models of chronic multiple sclerosis (MS), laying the foundation for the regenerative neuroimmunology field.[7][8] Since then, his research has delved into the mechanisms behind the therapeutic effects of NSCs, including their immunomodulatory and pro-regenerative properties.
Key discoveries from his lab include:
- Demonstrating how directly induced NSCs (iNSCs) respond to the immunometabolite succinate to suppress neuroinflammation, revealing a novel immune-metabolic crosstalk.[9]
- Identifying mitochondrial complex I in microglia as a regulator of chronic CNS inflammation, providing a new metabolic target for neuroprotection and therapeutic intervention.[10]
- Showing that iNSCs promote remyelination in chronic MS-like lesions by supporting endogenous repair mechanisms and directly generating myelin-producing cells.[11]
His work on the interaction between stem cells and immune cells has demonstrated that advanced stem cell therapies exert their effects not only through cellular replacement but also via modulation of mitochondrial function and neuroinflammatory pathways. This perspective has inspired first-in-kind clinical trials of allogeneic neural stem cells in patients with progressive MS, including a pioneering Phase I trial demonstrating the safety and feasibility of intracerebroventricular NSC transplantation.[12]
Further, his recent research employs advanced 2D and 3D stem cell models using patient-derived cells, revealing that neural progenitors from people with progressive MS exhibit a senescent, inflammatory phenotype that can be reversed with agents such as simvastatin.[13] His lab also identified MS-specific epigenetic changes and a previously unrecognized population of immature, senescent, proinflammatory radial glia-like cells (DARGs), which spread inflammation and senescence, offering new avenues for personalized treatments.[14]
Overall, Stefano Pluchino’s work integrates stem cell biology, neuroimmunology, immunometabolism, and patient-specific modelling to develop targeted therapies aimed at slowing or reversing MS progression. His insights into mitochondrial function, immune regulation, and regenerative strategies continue to shape cutting-edge approaches in neurodegenerative disease research with the goal of accessible, effective, patient-centred treatments.
Education
Born in 1971, Pluchino grew up in Ragusa, Italy. He attended liceo classico Umberto I in Ragusa. He earned an M.D., a full residency in Neurology and a Ph.D. in Experimental Neurosciences from the University of Siena, Italy (joint with San Raffaele Scientific Institute, Milan), under the mentorship of Gianvito Martino in 2004.[15][16][17] The title of his PhD thesis was 'Development of a neural stem cell-based therapy for experimental multiple sclerosis in mice'.
He then completed his post-doctoral research at San Raffaele Scientific Institute, and Vita-Salute San Raffaele University, Milan. He was also an instructor in Experimental Neurosciences at University Vita-Salute San Raffaele, Milan until 2010.
In 2010, Pluchino joined the faculty at the University of Cambridge – School of Clinical Medicine, with a laboratory at the Van Geest Centre for Brain Repair, on the Forvie site of the Cambridge Biomedical Campus. He became University Lecturer and Honorary Consultant in Neurology, as well as principal investigator at the Wellcome–MRC Cambridge Stem Cell Institute. He was promoted to University Reader in Regenerative Neuroimmunology in 2016. In 2021, Pluchino was further promoted to Professor of Clinical Regenerative Neuroimmunology, in the Department of Clinical Neurosciences.[18]
Research and career
Pluchino's research studies whether the accumulation of neurological disability observed in patients with chronic inflammatory neurological conditions can be slowed down using next generation molecular therapies.[7][8][19][20] The overarching aim is to understand the basic mechanisms that allow exogenously delivered stem cells, gene therapy vectors and/or exosomes[21][22][23][9][24] to create an environment that preserves damaged axons or prevents neurons from dying.[20][25][26] Such mechanisms may be harnessed and used to modulate disease states to repair and/or regenerate critical components of the nervous system.[27][28][12][29]
Awards and honors
- 2003 AINI Award
- 2003 European Charcot Foundation (ECF) Award
- 2004 SIICA Award
- 2006 Serono Foundation Multiple Sclerosis Award;
- 2007 FISM Rita Levi-Montalcini Award;
- 2008 Regional Agency for Instruction, Formation and Work (ARIFL) Research and Internationalization Award;
- 2010 Royan International Research Award;
- 2025 UConn Health Petit Family, Distinguished Visiting Professor in Multiple Sclerosis and Neuroimmunology;
References
- ^ a b "Stefano Pluchino - How stem cells speak with immune cells". YouTube. 26 January 2015.
- ^ "Cambridge Neuroscience - Stefano Pluchino - Regenerative Neuroimmunology: a stem cell perspective". YouTube. 8 June 2021.
- ^ a b "How Exosomes Are Revolutionizing Neuroimmunology with Dr. Pluchino". BioInformant. 29 June 2018.
- ^ Genovese, Giovanna (10 March 2018). "Lotta "personalizzata" con staminali alla sclerosi multipla: tre "cervelli" siciliani ci stanno lavorando". La Sicilia (in Italian).
- ^ "Sclerosi multipla, staminali domano l'infiammazione". Giornale di Sicilia (in Italian). 26 February 2018.
- ^ "Using stem cells to tackle CNS disorders: an interview with Dr Stefano Pluchino". News-Medical.net. 5 January 2016.
- ^ a b Pluchino, S; Quattrini, A; Brambilla, E; Gritti, A; Salani, G; Dina, G; Galli, R; Del Carro, U; Amadio, S; Bergami, A; Furlan, R; Comi, G; Vescovi, A L; Martino, G (April 2003). "Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis". Nature. 422 (6933): 688–694. Bibcode:2003Natur.422..688P. doi:10.1038/nature01552. PMID 12700753. S2CID 4412113.
- ^ a b Pluchino, S; Zanotti, L; Rossi, B; Brambilla, E; Ottoboni, L; Salani, G; Martinello, M; Cattalini, A; Bergami, A; Furlan, R; Comi, G; Constantin, G; Martino, G (July 2005). "Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism". Nature. 436 (7048): 266–271. Bibcode:2005Natur.436..266P. doi:10.1038/nature03889. PMID 16015332. S2CID 4416083.
- ^ a b Peruzzotti-Jametti, L; Bernstock, J D; Vicario, N; Costa, A S.H.; Kwok, C K; Leonardi, T; Booty, L M; Bicci, I; Balzarotti, B; Volpe, G (March 2018). "Macrophage-Derived Extracellular Succinate Licenses Neural Stem Cells to Suppress Chronic Neuroinflammation". Cell Stem Cell. 22 (3): 355–368. doi:10.1016/j.stem.2017.11.020. PMC 5757249. PMID 29304344.
- ^ Peruzzotti-Jametti, L; Willis, CM; Krzak, G; Hamel, R; Pirvan, L; Ionescu, RB; Reisz, JA; Prag, HA; Garcia-Segura, ME; Wu, V (2024). "Mitochondrial complex I activity in microglia sustains neuroinflammation". Nature. 628 (8006): 195–203. Bibcode:2024Natur.628..195P. doi:10.1038/s41586-024-07167-9. PMC 10990929. PMID 38480879.
- ^ Peruzzotti-Jametti, L; Vicario, N; Volpe, G; Rizzi, S; Kwok, C; Lombardi, I; Bergholt, MS; Barea-Moya, L; D'Angelo, A; Nicaise, AM (2025-10-03). "Remyelination of chronic demyelinated lesions with directly induced neural stem cells". Brain. 148 (10): 3505–3513. doi:10.1093/brain/awaf208. PMC 12493045. PMID 40622272.
- ^ a b Leone MA; Gelati M; Profico DC; Gobbi C; Pravatà E; Copetti M; Conti C; Abate L; Amoruso L; Apollo F; Balzano RF; Bicchi I; Carella M; Ciampini A; Colosimo C; Crociani P; D'Aloisio G; Di Viesti P; Ferrari D; Fogli D; Fontana A; Frondizi D; Grespi V; Kuhle J; Laborante A; Lombardi I; Muzi G; Paci F; Placentino G; Popolizio T; Ricciolini C; Sabatini S; Silveri G; Spera C; Stephenson D; Stipa G; Tinella E; Zarrelli M; Zecca C; Ventura Y; D'Alessandro A; Peruzzotti-Jametti L; Pluchino S; Vescovi AL (December 7, 2023). "Phase I clinical trial of intracerebroventricular transplantation of allogeneic neural stem cells in people with progressive multiple sclerosis". Cell Stem Cell. 30 (12): 1597–1609.e8. doi:10.1016/j.stem.2023.11.001. hdl:10281/453838. PMID 38016468.
- ^ Ionescu, RB; Nicaise, AM; Reisz, JA; Williams, EC; Prasad, P; Willis, CM; Simões-Abade, MBC; Sbarro, L; Dzieciatkowska, M; Stephenson, D (2024-11-07). "Increased cholesterol synthesis drives neurotoxicity in patient stem cell-derived model of multiple sclerosis". Cell Stem Cell. 31 (11): 1574–1590.e11. doi:10.1016/j.stem.2024.09.014. PMID 39437792.
- ^ Park, B; Nicaise, AM; Tsitsipatis, D; Pirvan, L; Zucha, D; Munteanu, A; Prasad, P; De Novales, MLL; Bulgaru, C; Kollyfas, R; Whitten, J; Willis, CM; Culig, L; Llewellyn, J; Ionescu, RB; Mekdad, M; Simões-Abade, MBC; Krzak, G; Fan, J; De S; Ellis, MO; Cubero, MS; Spathopoulou, A; Peruzzotti-Jametti, L; Leonardi, T; Balmus, G; Edenhofer, F; Gorospe, M; Valihrach, L; Mohorianu, I; Pluchino, S; Beerman, I (2025-10-10). "Integrated omics reveals disease-associated radial glia-like cells with epigenetically dysregulated interferon response in multiple sclerosis". Neuron: S0896-6273(25)00710-X. doi:10.1016/j.neuron.2025.09.022. PMID 41075785.
- ^ "Stefano Pluchino". Neurology Academy.
- ^ "Stefano Pluchino". www.eurostemcell.org.
- ^ "ORCID". orcid.org.
- ^ "Member: Stefano Pluchino". Cambridge Neuroscience.
- ^ Pluchino, S; Muzio, L; Imitola, J; Deleidi, M; Alfaro-Cervello, C; Salani, G; Porcheri, C; Brambilla, E; Cavasinni, F; Bergamaschi, A; Garcia-Verdugo, J M; Comi, G; Khoury, S J; Martino, G (October 2008). "Persistent inflammation alters the function of the endogenous brain stem cell compartment". Brain. 131 (Pt 10): 2564–2578. doi:10.1093/brain/awn206. PMID 18765417.
- ^ a b Bacigaluppi, M; Pluchino, S; Peruzzotti-Jametti, L; Kilic, E; Kilic, U; Salani, G; Brambilla, E; West, M J; Comi, G; Martino, G; Hermann, D M (August 2009). "Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms" (PDF). Brain. 132 (Pt 8): 2239–2251. doi:10.1093/brain/awp174. PMID 19617198.
- ^ Kalra, H; Simpson, R J; Ji, H; Aikawa, E; Altevogt, P; Askenase, P; Bond, V C; Borràs, F E; Breakefield, X; Budnik, V; Buzas, E I; Camussi, G; Clayton, A; Cocucci, E; Falcon-Perez, J M; Gabriel, S; Gho, Y S; Gupta, D; Harsha, H C; Hendrix, A; Hill, A F; Inal, J M; Jenster, G; Krämer-Albers, E M; Lim, S K; Llorente, A; Lötvall, J; Marcilla, A; Mincheva-Nilsson, L; Nazarenko, I; Nieuwland, R; Nolte-'t Hoen, E N; Pandey, A; Patel, T; Piper, M G; Pluchino, S; Prasad, T S K; Rajendran, L; Raposo, G; Record, M; Reid, G E; Sánchez-Madrid, F; Schiffelers, R M; Siljander, P; Stensballe, A; Stoorvogel, W; Taylor, D; Thery, C; Valadi, H; van Balkom, B W; Vázquez, J; Vidal, M; Wauben, M H M; Yáñez-Mó, M; Zoeller, M (December 2012). "Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation". PLOS Biol. 10 (12) e1001450. doi:10.1371/journal.pbio.1001450. PMC 3525526. PMID 23271954.
- ^ Cossetti, C; Iraci, N; Mercer, T R; Leonardi, T; Alpi, E; Drago, D; Alfaro-Cervello, C; Saini, H K; Davis, M; Schaeffer, J; Muller, W; Garcia-Verdugo, J M; Mathivanan, S; Bachi, A; Enright, A; Mattick, J S; Pluchino, S (April 2014). "Extracellular vesicles from neural stem cells transfer IFN-g via Ifngr1 to activate Stat1 signalling in target cells". Molecular Cell. 56 (2): 193–204. doi:10.1016/j.molcel.2014.08.020. PMC 4578249. PMID 25242146.
- ^ Iraci, N; Gaude, E; Leonardi, T; Costa, A S.H.; Cossetti, C; Saini, H K; Enright, A; Frezz, C; Pluchino, S (September 2017). "Extracellular vesicles are independent metabolic units delivering functional Asparaginase-like protein 1". Nature Chemical Biology. 13 (9): 951–955. doi:10.1038/nchembio.2422. PMC 5563455. PMID 28671681.
- ^ Peruzzotti-Jametti, L; Bernstock, JD; Willis, CM; Manferrari, G; Rogall, R; Fernandez-Vizarra, E; Williamson, JC; Braga, A; van den Bosch, A; Leonardi, T; Krzak, G; Kittel, A; Benincá, C; Vicario, N; Tan, S; Bastos, C; Bicci, I; Iraci, N; Smith, JA; Peacock, B; Muller, KH; Lehner, PJ; Buzas, EI; Faria, N; Zeviani, M; Frezza, C; Brisson, A; Matheson, NJ; Viscomi, C; Pluchino, S (September 2021). "Neural stem cells traffic functional mitochondria via extracellular vesicles" (PDF). PLOS Biol. 19 (9) e3001166. doi:10.1371/journal.pbio.3001166. PMC 8055036. PMID 33826607.
- ^ Cusimano, M; Biziato, D; Brambilla, E; Donegà, M; Alfaro-Cervello, C; Snider, S; Salani, G; Pucci, F; Comi, G; Garcia-Verdugo, J M; De Palma, M; Martino, G; Pluchino, S (February 2012). "Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord". Brain. 135 (Pt 2): 447–460. doi:10.1093/brain/awr331. PMC 3286199. PMID 22232595.
- ^ Smith, J A; Braga, A; Verheyen, J; Basilico, S; Alfaro-Cervello, C; Peruzzotti-Jametti, L; Haque, F; Guo, P; Pluchino, S (March 2018). "RNA nanotherapeutics for the amelioration of astroglial reactivity". Mol Ther Nucleic Acids. 10: 103–121. doi:10.1016/j.omtn.2017.11.008. PMC 5738063. PMID 29499926.
- ^ Pluchino, S; Gritti, A; Blezer, E; Amadio, S; Brambilla, E; Borsellino, G; Cossetti, C; Del Carro, U; Comi, G; 't Hart, B; Vescovi, A; Martino, G (September 2009). "Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates". Ann Neurol. 66 (3): 343–354. doi:10.1002/ana.21754. PMID 19798638. S2CID 42755439.
- ^ Braga, A; Bandiera, S; Verheyen, J; Hamel, R; Rutigliani, C; Edenhofer, F; Smith, J A; Pluchino, S (December 2020). "Combination of in situ Lcn2 pRNA-RNAi nanotherapeutics and iNSC transplantation ameliorates experimental spinal cord injury in mice". Mol Ther. 28 (12): 2677–2690. doi:10.1016/j.ymthe.2020.08.001. PMC 7704756. PMID 32877696.
- ^ "Multiple sclerosis breakthrough could lead to treatments that halt disease's progression". ITV News.
External links
- Stefano Pluchino - Top Italian Scientist in Neurosciences & Psychology
- Cambridge Immunology Network
- PluchinoLab website
- Preserving the Brain | Forum on neurodegenerative diseases
- Stefano Pluchino's lecture at "Premio Rita Levi Montalcini". FISM Congress 2022
- Stefano Pluchino publications indexed by Google Scholar